Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Neoplasms by Histologic Type × olaparib × 30 days × Clear all

Sponsor

Conditions

Ovarian Neoplasms 16 Fallopian Tube Neoplasms 12 Triple Negative Breast Neoplasms 7 Breast Neoplasms 6 Neoplasms 4 Endometrial Neoplasms 4 Prostatic Neoplasms 3 Pancreatic Neoplasms 3 Neoplasm Metastasis 3 Parkinson Disease 4, Autosomal Dominant Lewy Body 2 Multiple Myeloma 2 Metastatic Castration-resistant Prostate Cancer 2 Lymphoma, Non-Hodgkin 2 Glioma 2 Glioblastoma 2 Carcinoma 2 Uterine Cervical Neoplasms 1 Urinary Bladder Neoplasms 1 Stomach Neoplasms 1 Solid Tumors 1 Sarcoma 1 Recurrent Ovarian High Grade Serous Adenocarcinoma 1 Recurrence 1 Prostatic Neoplasms, Castration-Resistant 1 Pheochromocytoma 1 Pathologic Complete Response 1 Paraganglioma 1 Osteosarcoma 1 Inflammatory Breast Neoplasms 1 High Grade Serous Carcinoma 1

Interventions

trametinib 1 pralsetinib 1 ponatinib 1 pembrolizumab 1 fludarabine phosphate 1 fludarabine 1 durvalumab 1 dabrafenib 1 Whole-Body Irradiation 1 Tacrolimus 1 Peripheral Blood Stem Cell Transplantation 1 Pemetrexed 1 Patient Reported Outcome Measures 1 Paclitaxel 1 Mycophenolic Acid 1 Mesna 1 Melphalan 1 Immunotherapy 1 Gemcitabine 1 Cyclophosphamide 1 Cisplatin 1 Carboplatin 1 Busulfan 1 Bone Marrow Transplantation 1 Biopsy 1 130-nm albumin-bound paclitaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡